High pulmonary pressure on echo: is it PAH? A Shanghai cause-focused assessment
PAH versus pulmonary hypertension assessment Shanghai
“Pulmonary hypertension” on an echocardiogram is the start of a diagnostic question, not automatically pulmonary arterial hypertension (PAH). Heart disease, lung disease and chronic blood clots can require different paths. Shanghai’s cross-specialty resources can help classify the cause before a specific drug or procedure is chosen.
By eastmedgo editorial ·
On this page
Use the diagnosis precisely
PAH involves disease of the smaller pulmonary arteries. Pulmonary hypertension can also arise from left-heart disease, lung disease or low oxygen, chronic clot-related obstruction and other conditions. These categories are not interchangeable, even though breathlessness and fatigue may overlap. A report saying that pulmonary artery pressure is elevated therefore does not identify the correct treatment by itself. Ask whether the clinician is describing a suspected finding, confirmed pulmonary hypertension or a specific PAH diagnosis. Accurate terminology matters because a medicine appropriate for one mechanism is not automatically appropriate for another.
Sources and references: [1]
An echocardiogram estimates and describes; it does not answer everything
Echo can estimate pressure and show how the right and left sides of the heart are functioning. Those findings help guide investigation, but an estimated pressure alone cannot establish PAH. When indicated, right-heart catheterisation directly measures pressures and provides information needed for confirmation and interpretation. It is an invasive specialist test, so its purpose should be clear rather than assumed for every visitor. Ask what uncertainty remains after the echo, what the proposed investigation would clarify and whether the result would change the treatment plan. Bring the full report rather than only the highlighted number.
Sources and references: [2]
The cause determines the next branch of the assessment
A history of left-heart or valve disease raises different questions from significant lung disease or low oxygen. Previous pulmonary embolism requires attention to chronic thromboembolic disease; it should not be folded into PAH simply because pulmonary pressure is high. PAH itself may be associated with connective-tissue disease, congenital heart disease, portal hypertension, certain exposures or no identified associated cause. More than one problem can coexist. The specialist's task is to determine which mechanism best explains the findings and whether another condition contributes enough to change management, rather than forcing every patient into the same pathway.
Sources and references: [1]
Select tests to distinguish plausible mechanisms
Depending on the history and existing results, assessment may include lung-function testing, blood tests, exercise assessment or a ventilation-perfusion scan to investigate clot-related obstruction. These tests have different purposes. A longer list is not automatically a better assessment, and not everyone needs every investigation repeated. Ask which result supports each suspected cause and which important alternatives remain untested. Symptoms during ordinary activity and at rest also help describe functional impact, but functional limitation is different from the cause classification. A useful review records both: what is driving the pressure problem and how severely it affects daily life.
Sources and references: [2]
Treatment follows the group, severity and individual risks
Where left-heart or lung disease is responsible, management focuses on the underlying condition. Specialist pulmonary vascular medicines are selected for appropriate clinical situations; they should not be started solely because an echo number is high. Chronic thromboembolic pulmonary hypertension may lead to consideration of anticoagulation and, in selected patients, pulmonary endarterectomy or balloon pulmonary angioplasty. Those procedures are not general PAH treatments. Ask what the proposed therapy is intended to improve and how response and adverse effects will be monitored.
Sources and references: [3]
Zhongshan’s cross-specialty review of pulmonary pressure
Zhongshan Hospital’s pulmonary hypertension multidisciplinary group, described by Fudan University in 2023, brought together cardiology, cardiac surgery, respiratory medicine, rheumatology and imaging. That combination is valuable when an elevated echo estimate has several possible causes: the specialists can examine the heart, lungs, thromboembolic history and connective-tissue disease together. The goal is a defensible classification and a treatment path matched to the mechanism, rather than a new medicine chosen from one echo number. Explore the Zhongshan Hospital profile and Pulmonary arterial hypertension guide to prepare focused questions.
Sources and references: [4]
Prepare a cause-focused consultation package
Bring complete echocardiography and any right-heart catheter results, chest imaging, lung-function and ventilation–perfusion studies if available, plus records of heart disease, clots, autoimmune disease and current medicines. Note how far you can walk and when breathlessness or fainting began. eastmedgo helps organize this material and route the case toward the relevant Shanghai specialists, coordinating language and visit steps by agreement. Ask the team what diagnosis is established, what important cause remains untested and which investigation would change the plan.
Plan the costs and follow-up before changing treatment
Budget for a staged assessment: specialist review, selected investigations, and treatment only after the cause is clear. If medication changes, arrange reliable supply and a local doctor to monitor symptoms and side effects. New persistent chest pain, fainting or severe breathlessness requires urgent care where you are. eastmedgo can help organize reports and the return-home handover. Share the full echo, any right-heart catheter data and lung or clot tests with eastmedgo to discuss “which pulmonary hypertension cause is present and what treatment follows” with the right Shanghai team.
Common questions
Does a high pulmonary pressure on echo mean I need PAH-targeted medicine?
No. Echo findings need interpretation, and PAH must be distinguished from other causes of pulmonary hypertension. Treatment depends on the underlying mechanism and the complete assessment.
Is balloon pulmonary angioplasty a treatment for every PAH patient?
No. It is considered for selected chronic thromboembolic disease, a different category of pulmonary hypertension. It should not be presented as a routine procedure for PAH generally.
Sources and references: [3]
What should I send before a Shanghai pulmonary hypertension review?
Send complete echo reports and images, any right-heart catheter data, lung and clot investigations, medicine list and a timeline of breathlessness or fainting. The first useful answer is which pulmonary hypertension category best fits and what test will clarify it.